A clinical study of the compound Astra 2045 in the treatment of bovine hypocalcaemia with special reference to dosage levels.
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001224:Aspartic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002118:Calcium / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006996:Hypocalcemia / Q000188:drug therapy / Q000662:veterinary*; D007275:Injections, Intravenous; D008274:Magnesium / Q000627:therapeutic use*; D010246:Paralysis, Obstetric / Q000188:drug therapy / Q000662:veterinary; D010919:Placebos; D011188:Potassium / Q000627:therapeutic use*; D011247:Pregnancy
D010919:Placebos; D001224:Aspartic Acid; D008274:Magnesium; D011188:Potassium; D002118:Calcium